These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 23789754)
1. Extemporaneous clobazam suspensions for paediatric use prepared from commercially available tablets and pure drug. Buontempo F; Moretton MA; Quiroga E; Chiappetta DA Farm Hosp; 2013; 37(2):103-10. PubMed ID: 23789754 [TBL] [Abstract][Full Text] [Related]
2. Extemporaneous benznidazole oral suspension prepared from commercially available tablets for treatment of Chagas disease in paediatric patients. García MC; Manzo RH; Jimenez-Kairuz AF Trop Med Int Health; 2015 Jul; 20(7):864-70. PubMed ID: 25784402 [TBL] [Abstract][Full Text] [Related]
3. Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding. Zhao F; Dave VS; Mar MZ; Perri JR Int J Pharm Compd; 2018; 22(5):433-439. PubMed ID: 30384342 [TBL] [Abstract][Full Text] [Related]
4. Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets. Sosnowska K; Winnicka K; Czajkowska-Kośnik A Acta Pol Pharm; 2009; 66(3):321-6. PubMed ID: 19645333 [TBL] [Abstract][Full Text] [Related]
5. Stability and uniformity of extemporaneous preparations of voriconazole in two liquid suspension vehicles at two storage temperatures. Nguyen KQ; Hawkins MG; Taylor IT; Wiebe VJ; Tell LA Am J Vet Res; 2009 Jul; 70(7):908-14. PubMed ID: 19566477 [TBL] [Abstract][Full Text] [Related]
6. Characterization of an extemporaneous liquid formulation of lisinopril. Thompson KC; Zhao Z; Mazakas JM; Beasley CA; Reed RA; Moser CL Am J Health Syst Pharm; 2003 Jan; 60(1):69-74. PubMed ID: 12533979 [TBL] [Abstract][Full Text] [Related]
7. Physicochemical and Microbiological Stability of Compounded Bethanechol Chloride Oral Suspensions in PCCA Base, SuspendIt®. Pramar YV; Davis C; Ip K; Banov D Int J Pharm Compd; 2024; 28(4):321-328. PubMed ID: 39094044 [TBL] [Abstract][Full Text] [Related]
9. Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt. Pramar YV; Mandal TK; Bostanian LA; Le G; Morris TC; Graves RA Int J Pharm Compd; 2020; 24(5):413-419. PubMed ID: 32886640 [TBL] [Abstract][Full Text] [Related]
10. Stability of acetazolamide in suspension compounded from tablets. Alexander KS; Haribhakti RP; Parker GA Am J Hosp Pharm; 1991 Jun; 48(6):1241-4. PubMed ID: 1858804 [TBL] [Abstract][Full Text] [Related]
11. Stability of extemporaneous sulfadiazine oral suspensions from commercially available tablets for treatment of congenital toxoplasmosis. Soares Rodrigues Costa B; Pontes do Nascimento L; Vítor de Paiva Amorim M; Barreto Gomes AP; Mafra Veríssimo L Trop Med Int Health; 2020 Mar; 25(3):364-372. PubMed ID: 31802579 [TBL] [Abstract][Full Text] [Related]
12. Formulation and stability of diazepam suspension compounded from tablets. Strom JG; Kalu AU Am J Hosp Pharm; 1986 Jun; 43(6):1489-91. PubMed ID: 3728485 [TBL] [Abstract][Full Text] [Related]
13. The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions. Svirskis D; Lin SW; Brown H; Sangaroomthong A; Shin D; Wang Z; Xu H; Dean R; Vareed P; Jensen M; Wu Z Int J Pharm Compd; 2018; 22(2):164-171. PubMed ID: 29877863 [TBL] [Abstract][Full Text] [Related]
14. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation. Pabari RM; McDermott C; Barlow J; Ramtoola Z Clin Ther; 2012 Nov; 34(11):2221-9. PubMed ID: 23149007 [TBL] [Abstract][Full Text] [Related]
15. Stability of extemporaneous erlotinib, lapatinib, and imatinib oral suspensions. Li Q; Liu Z; Kolli S; Wetz K; Griffith N; Poi MJ Am J Health Syst Pharm; 2016 Sep; 73(17):1331-7. PubMed ID: 27543577 [TBL] [Abstract][Full Text] [Related]
16. Stability of hydrocortisone oral suspensions prepared from tablets and powder. Fawcett JP; Boulton DW; Jiang R; Woods DJ Ann Pharmacother; 1995 Oct; 29(10):987-90. PubMed ID: 8845559 [TBL] [Abstract][Full Text] [Related]
17. The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment. Meissner S; Bansal M; Dela CPD; Hanning S; Svirskis D Int J Pharm Compd; 2020; 24(2):140-147. PubMed ID: 32196476 [TBL] [Abstract][Full Text] [Related]